source
- WuXi AppTec lifts 2026 revenue outlook despite US defense designation disputeWuXi AppTec, a leading Chinese contract research and manufacturing organization, announced it has again lifted its revenue forecast for 2026. The company said the upward revision reflects accelera…
- SystImmune/BMS and Hengrui showcase ADC data for EGFR-mutant lung cancer at ESMOAt the European Society for Medical Oncology (ESMO) meeting in Madrid, Li Zhang of Sun Yat-sen University Cancer Center presented early data from the HERON‑Lung01 study, highlighting an antibody‑dr…